» Industry News » China’s COVID-19 Oral Pill Gets Regulatory Approval

China’s COVID-19 Oral Pill Gets Regulatory Approval

2022-07-27

China’s top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.

Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.

The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.

 

China Daily

Maybe you like also

  • ABOUT US

    Medico Technology Co., Ltd. is a manufacturer located in Shenzhen City, China, we produce and sale nylon flocked swabs, virus transport medium, saliva collection kit and CHG Swab & Applicator.

  • CONTACT US

    Address: 17 Hengyi lane, Yuanhu Road, Zhangbei community, Longcheng street, Longgang District, Shenzhen,Guangdong,China.

    Web:  www.medicoswab.com

    Phone Number:  +86 0755-28997664

    Email: info@medicoswab.com